InvestorsHub Logo
icon url

Reyeton

05/01/17 11:01 AM

#103610 RE: Franz1969 #103595

The demographics of sex, gender and age in this study would provide no value in our upcoming Phase 3. Hopefully, the demographics of our trial will be based on a biologic profile that is being defined using our present data to identify those that would benefit most. Our new hire should have great insite on how to design this.